Healthcare, Aerospace and Capital: Why the Overlap Matters
Medicine and spaceflight share more than it seems: both depend on understanding radiation, on rigorous testing, and on capital patient enough to build hard things.
4 min read
People sometimes ask why an interventional cardiologist is involved in aerospace. The short answer is that the two fields overlap more than they appear to. Both depend on understanding radiation and its effects, both are governed by a culture of rigorous testing, and both need capital that is willing to wait for difficult work to pay off.
Radiation is a shared problem
In medicine, radiation is both a tool and a hazard. Imaging, nuclear cardiology and radiation therapy rely on it; dose limits, shielding and careful measurement exist because of it. Nuclear cardiology is one of the specialties I trained in, and keeping radiation dose as low as reasonably achievable is part of everyday practice in a cath lab.
Spaceflight meets the same physics from the other side. Beyond the protection of Earth’s atmosphere and magnetic field, energetic particles affect people and electronics alike. For astronauts, cumulative radiation exposure is one of the main health considerations on long missions. For spacecraft, a single particle can disrupt a chip. I described how that testing works in Radiation-Effects Testing and the New Space Economy.
The two worlds even share equipment. Proton beams of the kind used in cancer treatment are also used to test how electronics behave under radiation, and many of the facilities that offer such testing are shared with medical treatment or research. Aerospace Research Center was built around a 230 MeV proton cyclotron dedicated to radiation-effects testing for space, defense and research customers.
Both fields run on testing
Medicine and aerospace are among the few industries in which failure can be measured in lives, and both have responded in similar ways: protocols, checklists, independent verification and a habit of learning from every incident. A new device does not reach a patient, and a new component does not reach orbit, without evidence that it will behave as intended.
That shared culture makes moving between the fields easier than one might expect. The questions a physician asks of a clinical study (how was it measured, under what conditions, has the result been reproduced) are the questions an engineer asks of a test report.
Hard things need patient capital
The third overlap is financial. Specialised clinics, testing facilities and spacecraft share an uncomfortable feature: they require large commitments long before they produce revenue, and they take years of careful operation to pay off. Capital that needs results by the next quarter is poorly suited to them. So is capital that cannot judge the technical risk: an investor who does not understand why a test facility needs years of validation, or why a clinic needs time to build trust with patients and referring physicians, is likely to lose patience at exactly the wrong moment.
That is a large part of why I think about investment in terms of long-term ownership at Impero Capital Holdings. A single-family office can afford to be patient where patience is warranted, and to hold specialised infrastructure through the long period in which it matures. It also has to be disciplined about which hard things deserve that patience, which is where the habits of calculated risk come in.
Why the overlap matters
Fields that develop separately tend to relearn each other’s lessons. Medicine borrowed checklists and team-communication training from aviation; aerospace, in turn, draws on medicine’s long experience of how the human body tolerates radiation and stress. People and capital that move between the fields carry those lessons with them.
For me, the connection is personal as well as practical. Medicine was the foundation, and healthcare, aerospace testing and long-term investment were built around it. The common thread is respect for evidence, for risk and for the time it takes to build something that lasts. More about that path is on my biography page.
About the author. Irfan Siddiqui is a physician, entrepreneur and investor with more than twenty-five years in medicine. He founded Impero Capital Holdings, a single-family office, and is the physician behind Regenerative Health & Wellness (concierge medicine) and Expert Medical Advisors & Consultants (independent medical review). Read his full biography.